Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

FinScreener

EUR/USD

1.1994

0.0037

0.31%

GBP/USD

1.3511

-0.0001

-0.01%

USD/JPY

111.60

0.1100

0.10%

USD/CHF

0.9626

0.0008

0.09%

EUR/GBP

0.8877

0.0029

0.32%

USD/CAD

1.2293

0.0014

0.11%

NZD/USD

0.7315

0.0057

0.78%

EUR/JPY

133.85

0.5465

0.41%

EUR/CHF

1.1544

0.0045

0.39%

Acura Pharmaceuticals Inc.

NASDAQ: ACURHealthcare / Drug Delivery / USA
0.443-0.027-5.72%Vol 29 6281Y Perf -71.96%
Sep 19th, 2017 15:38
BID0.00 ASK0.00
Open0.46 Previous Close0.47
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.00 
Analyst Rating
Strong Buy 1.00
Potencial %
1 254.10 
Finscreener Ranking
    40.89
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
    23.00
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
    33.76
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)9 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
2.87 
Earnings Date
13th Nov 2017

Today's Price Range

0.440.47

 

52wk Range

0.4011.87

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
6.82%
3 Months
-7.84%
6 Months
-17.54%
1 Year
-71.96%
3 Years
-88.10%
5 Years
-95.00%
Last Quotes
Name / TickerPriceChg.Chg.%
ACUR0.443-0.0269-5.72
AAPL158.730.06000.04
GOOG921.816.81000.74
MSFT75.440.28000.37
XOM80.220.13000.16
WFC53.360.65001.23
JNJ135.22-0.1600-0.12
FB172.522.51001.48
GE24.20-0.2600-1.06
JPM93.941.02001.10
...

TickerPriceChg.%52 Week High
LUK24.293.9427.33
KORS46.183.4352.67
NRG24.623.2726.25
AA46.202.8746.44
PGR47.632.8549.01
MGM32.562.7834.65
ALB134.652.77135.26
NTAP41.712.6645.24
DE123.082.66132.50
VZ49.342.6054.83
FCX14.482.4817.06
WYNN147.012.20147.50
T38.212.1143.03
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.30
Current Ratio 0.90
Long Term Debt to Total Capital 0.56
Total Debt to Equity 2.88
Interest Coverage -2.30
Leverage Ratio 14.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin94.80
EBIT Margin-25.20
EBITDA Margin-20.40
Pre-tax Profit Margin-
Profit Margin-40.40
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.84
PS Ratios 1.41
Price to Cash Flow 12.10
Price to Free Cash Flow -10.90
Cash Flow Per Share -0.07
Price to Tangible Book-5.80
Book Value per Share-0.02
Enterprise Value (in ths.)12 774
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-66.48
ROE last 12 Months -360.73
Return on Assets (5Y Avg) -109.02
ROA last 12 Months -29.36
Return on Capital (5Y Avg) -42.76
ROC last 12 Months -27.61
Return on invested Capital Q -37.47
Return on invested Capital Y-58.55
Assets Turnover0.60
Receivables Turnover105.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)6 792
Revenue per Share 0.33
Revenue Growth 3 Years 143.22
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2017-0.11-0.18-63.64
Q01 2017-0.110.03127.27
Q04 2016-0.270.13148.15
Q03 2016-0.27-0.1929.63
Q02 2016-0.28-0.280.00
Q01 2016-0.25-0.28-12.00
Q04 2015-0.03-0.08-166.67
Q03 20150.00-0.23-
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.120.00-
12/2017 QR-0.120.00-
12/2017 FY-0.460.00-
12/2018 FY0.380.00-
Next Report Date13th Nov 2017
Estimated EPS Next Report-0.12
Estimates Count1
EPS Growth Next 5 Years %0.00
Volume Overview
Volume29 628
Shares Outstanding (in ths.)20 800
Trades Count12
Dollar Volume12 765
Avg. Volume196 785
Avg. Weekly Volume20 706
Avg. Monthly Volume14 901
Avg. Quarterly Volume11 133

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

68%32%

Bearish Bullish

65%35%

Bearish Bullish

82%18%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x